GENEGUT

📣 We are pleased to share that at the recent CoMH Research Conference Futures 2024, Miguel Ramôa presented his work on developing polymeric nanoparticles for oral RNA delivery as a potential treatment for ileal Crohn's disease. Several young researchers from the GENEGUT consortium also contributed with engaging poster presentations, highlighting the research within the project in Cork on 12th December. #GENEGUT #CrohnsDisease #NanoparticleDelivery #RNAtherapeutics #CoMH2024 Sophia Hoffmann Klara Martinovic Music Ana Francisca Soares Aman Saifi

The fifth issue of the EFCCA Projects Digest is now available! This issue covers the latest updates on our EU funded projects: GENEGUT, GlycanTrigger EU Project, miGut-Health, FIBROTARGET, METHYLOMIC_EU, IDEA-FAST and ImmUniverse. Stay informed and explore the latest in our research efforts💡 👉 Read it here: https://bit.ly/40JF4U3 #ResearchInitiatives #EFCCA #ProjectsDigest #HorizonEurope

Today, my colleague Alina Meyer and I just wrapped up a remarkable opportunity to attend HUPO 2024, Dresden, Germany ! The conference was incredibly insightful, and it was an absolute pleasure to meet and listen to so many brilliant minds from proteomics field. I also got a chance to present my work conducted within the Artursson Lab and GENEGUT as the poster presentation to participants during the conference. A special thank you to Madlen Hubert, Per Artursson, and Mikael Sellin for your guidance and support throughout this journey. And a huge thank you to Swedish Proteomics Society and HUPO for making my travel possible and giving me the opportunity to participate. #GENEGUT #proteomics #HUPO2024

🎓 Proud moment for the GENEGUT project! Several of our incredible collaborators have been recognised among the Top 2% Scientists globally by Stanford University for their significant research contributions. Their excellence in research, particularly in healthcare sciences, highlights not only their individual talent but also the strength of our collective efforts in advancing gut health solutions. Huge congratulations to our team members—you continue to make waves in the world of innovation! 🌍🔬 ▶️ See the listed scientists on our website: https://lnkd.in/dQGFy8xb #ResearchImpact #HealthcareInnovation #GENEGUT Caitriona O'Driscoll Brendan Griffin Piotr Kowalski Subrata Ghosh #Dyfrig Hughes Per Artursson Bruno Sarmento Vincent Jannin

📣 The new European Federation of Crohn's and Ulcerative Colitis Associations magazine is out! Read about #IBD research by Prof. James Lee, the World IBD Day 2024, their new guidebook on Health Technology Assessment and much more ⤵️

GENEGUT will be present at NEI2024 next friday! Our group #NTDD will showcase the in vitro model used to test novel RNA-based therapies for Crohn's disease. Don't miss it! #NEI2024 is OPEN to all! 🤗 European Researchers' Night🌃🥼 📅 27 September 🕕 18h 📍 i3S - Instituto de Investigação e Inovação em Saúde 30 experimental activities on display for you to try and play with, but there's also a riveting auditorium program that you simply cannot miss! 𝗙𝗿𝗲𝗲 𝗲𝗻𝘁𝗿𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗻𝗼 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝗱. We'll see you there😊 #EuropeanResearchNight #NoiteEuropeiadosInvestigadores2024 #NoiteEuropeiadosInvestigadores2025 #NEI2024 #NEI2025 #MSCAcitizens #EUprojects #EUfunding #EU_Embraces #HorizonEurope #HEurope #NEI2024_25 #CiênciaParaTodos

In my first review paper, recently published in the European Journal of Pharmaceutical Sciences, we examine the current state of smart drug delivery capsules and how incorporating recent technological advancements could enable precise, remotely controlled drug delivery to specific regions of the GI tract. This could have a transformative impact on treating conditions like inflammatory bowel disease. 🚀 A big thank you to my co-authors Brendan Griffin, Joseph O'Shea (School of Pharmacy, UCC), Vincent Jannin (Lonza Capsules & Health Ingredients), and Paul Galvin (Tyndall National Institute) for their collaboration on this exciting work! 🤝 This review is funded by the European Union as part of the GENEGUT project, which focuses on developing a novel nanoparticle RNA therapy for the treatment of ileal Crohn’s disease. Read the article here: https://lnkd.in/dtTs7_6A Looking forward to what the future holds for precision medicine in gastrointestinal disorders! 🎯 #smartcapsule #drugdelivery #IBD #crohnsdisease #GENEGUT

📣 Yet another presentation, this time at the 21st International Pharmaceutical Technology Symposium by GENEGUT coordinator Caitriona O'Driscoll. Her talk on "Innovative advances in non-viral delivery of RNA medicines" was a great opportunity to share the latest advances in the GENEGUT project with the scientific community! #IPTS2024

Yesterday was the first time we presented CarboHyde - GENEGUT results in public. Kristóf Felegyi and Balázs Attila Kondoros represented us at the annual gathering of Hungarian Pharmaceutialc Technology and Chemistry. Kristof's talk was about amphiphic cyclodextrin he made, their chemistry, formulation into nanoparticles and performance in delivering siRNA in various biological models. You did a fantastic job, Kristof, we are proud of you! #drugdelivery #genetherapy #rna #crohnsdisease

GENEGUT was recently represented by Sophia Hoffmann and Miguel Ramôa at the All-Ireland Schools of Pharmacy Conference at the Royal College of Surgeons in Ireland (RCSI). Congratulations on your presentations!